Loading clinical trials...
Loading clinical trials...
A Randomized Controlled Trial of ZYNRELEF Versus Standard of Care for Pain Management Following Unilateral Total Knee Arthroplasty
Conditions
Interventions
Bupivacaine-Meloxicam 400 Mg-12 Mg/14 mL Injectable Solution, Extended Release
Locations
1
United States
Doctors Hospital
Miami, Florida, United States
Start Date
March 9, 2023
Primary Completion Date
October 1, 2027
Completion Date
December 1, 2027
Last Updated
April 18, 2025
NCT07482709
NCT07041736
NCT07310953
NCT07226076
NCT07223580
NCT07364578
Lead Sponsor
Baptist Health South Florida
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions